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Abstract
The mechanism for hemorrhage enlargement in the brain, a key determinant of patient outcome following hemorrhagic
stroke, is unknown. We performed computer-based stochastic simulation of one proposed mechanism, in which
hemorrhages grow in ‘‘domino’’ fashion via secondary shearing of neighboring vessel segments. Hemorrhages were
simulated by creating an initial site of primary bleeding and an associated risk of secondary rupture at adjacent sites that
decayed over time. Under particular combinations of parameters for likelihood of secondary rupture and time-dependent
decay, a subset of lesions expanded, creating a bimodal distribution of microbleeds and macrobleeds. Systematic variation
of the model to simulate anticoagulation yielded increases in both macrobleed occurrence (26.9%, 53.2%, and 70.0% of all
hemorrhagic events under conditions simulating no, low-level, and high-level anticoagulation) and final hemorrhage size
(median volumes 111, 276, and 412 under the same three conditions), consistent with data from patients with
anticoagulant-related brain hemorrhages. Reversal from simulated high-level anticoagulation to normal coagulation was
able to reduce final hemorrhage size only if applied relatively early in the course of hemorrhage expansion. These findings
suggest that a model based on a secondary shearing mechanism can account for some of the clinically observed properties
of intracerebral hemorrhage, including the bimodal distribution of volumes and the enhanced hemorrhage growth seen
with anticoagulation. Future iterations of this model may be useful for elucidating the effects of hemorrhage growth of
factors related to secondary shearing (such as small vessel pathology) or time-dependent decay (such as hemostatic
agents).
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Introduction
Spontaneous bleeding into the brain (intracerebral hemor-
rhage, ICH) represents a common and highly lethal form of
stroke, with 3-month mortality of approximately 25% [1]. Large
hemorrhage volume at presentation and subsequent hemorrhage
expansion are strong predictors of poor post-ICH outcome
[2,3]. ICH in patients taking anticoagulant medications is
associated with larger initial hemorrhage volumes than ICH in
untreated individuals, greater likelihood of hematoma expan-
sion, and an even higher 3-month mortality of 50% or greater
[1,4–7].
A major barrier to developing effective therapies to reduce
the clinical burden of ICH is our poor understanding of the
determinants of hemorrhage size and mechanisms for growth.
Brain hemorrhages can occur as large symptomatic macrobleeds
or small, clinically asymptomatic cerebral microbleeds [8]. An
MRI-based analysis of patients with cerebral amyloid angiop-
athy-related hemorrhage [9] suggested macrobleeds and micro-
bleeds do not form a single continuum of volumes, but instead
comprise two distinct peaks that can be separated by a diameter
cut-point of approximately 0.6 cm. The basis for this bimodal
distribution has not been identified.
One possible mechanism that could generate distinct popu-
lations of microbleeds and macrobleeds is a threshold model,
whereby once a nascent hemorrhage reaches a particular size, it
continues to grow, becoming a macrobleed. Such a feed-
forward mechanism for hemorrhage growth was suggested by
early neuropathological studies showing secondary shearing of
blood vessels surrounding a hematoma [10]. Fisher interpreted
these data as hemorrhages growing in ‘‘domino’’ or ‘‘avalanche’’
fashion, one ruptured vessel triggering bleeding from the next.
We created a computer-based simulation to explore the
properties of hemorrhages generated by secondary shearing of
adjacent vessels. We analyzed the lesions’ size distribution,
growth pattern, and response to prolonged decay of secondary
shearing (to simulate the effects of anticoagulation).
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Simulation of Hemorrhage Expansion
We simulated hemorrhage growth on a three-dimensional
lattice comprised of virtual vessel segments, arrayed in a
15061506150 cubic pattern. Each run of the simulation begins
with an initial rupture of a vessel segment (the primary bleeding
event) at the center of the lattice (Fig. 1A, shown as a two-
dimensional lattice for simplicity). In the next cycle, the primary
bleed introduces the possibility of rupture at each neighboring
segment (Fig. 1B), simulating the process of secondary shearing
[10]. Any secondary bleeding that indeed occurs contributes in
turn to the possibility that other neighboring segments will rupture
in subsequent cycles (Fig. 1C–D). The effect of multiple
neighboring bleeds is additive, leading to possible cascading
patterns of hemorrhage growth. The probability that any
particular vessel will bleed is re-evaluated in each cycle.
To simulate the simultaneously occurring process of coagulation
and clotting, the probability of secondary rupture contributed
from a bleed to its neighbors decreases exponentially towards zero
with each passing cycle. We also simulated the effect of increasing
local pressure from surrounding tissue as a size-dependent
decrease in the probability of further vessel ruptures. Hemorrhages
were visualized using the geometry module of ROOT (http://
root.cern.ch/).
Simulation Parameters
To perform the simulation, three parameters of the model are
specified. These are 1) an expansion constant a (unitless),
representing the factor determining the likelihood of secondary
shearing of adjacent vessels, 2) a time constant t (units of cycles),
representing the exponential falloff of the probability of shearing
with increasing time since the onset of a particular vessel’s bleeding
(simulating coagulation), and 3) a pressure constant b (units of
ruptured vessels), representing the falloff in probability of further
vessel rupture with increasing total hemorrhage volume (simulat-
ing local pressure effects). These parameters were systematically
varied (see below) to determine their effects on the resulting
simulated hemorrhages.
With these parameters specified, the total score for vessel
segment j to rupture (pj) in a given cycle is given by the following
expression, summed over all ruptured neighboring segments i:
pj~
X
i
a:exp {
ai
t
z
s
b
zdij
     
In addition to the specified parameters, the other variables in this
expression are ai, the number of simulation cycles since neighbor
vessel i ruptured; s, the total volume (measured in ruptured vessels)
of the hemorrhage; and dij, the center-to-center distance between
vessels i and j. Whether a neighboring vessel segment ruptures in a
given cycle is determined by whether the score exceeds a number
between 0 and 1 randomly chosen for that segment and cycle.
Neighbor vessels are those within two vessels in all directions
(including corners).
Analysis of Simulated Hemorrhagic Lesions
Each simulation was allowed to continue until hemorrhage
growth ceased (see representative example in Fig. 2), defined as
occurring when the highest score for a new vessel rupture at the
site of the most recent rupture was 10
26. Following each run, the
volume of the hemorrhagic lesion (measured as the total number
of ruptured vessels) was recorded and the results binned using a
natural log scale. Under certain parameter choices, we observed
two peaks in the lesion size histogram, which we divided at the
intervening bin with the lowest lesion count and designated as the
microbleed (lower volume) and macrobleed (higher volume) peaks.
Single vessel ruptures generally dominated the microbleed peak,
whereas the macrobleed peak consisted of lesions resulting from
secondary rupture.
For each choice of the parameters a, t, and b, we ran 10,000
simulations and recorded the size distribution histograms. The
simulations were performed on the University of California San
Francisco QB3 Shared Computing Facility, a mixed-architecture
Linux HPC grid with 3000 processor nodes. The 10,000
simulations typically required 100 to 3000 CPU-seconds, with
larger hemorrhages requiring more simulation time.
Parameter Search
We tested a range of values of the parameters a, t, and b to look
for regions in the parameter space that would yield a bimodal
distribution of hemorrhage volumes as observed in patients. Each
parameter was systematically increased through a range of values,
holding the other two parameters constant. Increases in each
parameter tend to enhance hemorrhage growth: a raises the
likelihood of secondary ruptures, t increases the time during which
vessels continue to induce ruptures of their neighbors, and b
enlarges the volumes at which local pressure prevents further
ruptures. To improve the efficiency of the computations, we
therefore followed a strategy of discontinuing further increases in a
parameter when the generated population of macrobleeds was 8
times the population of microbleeds, as further increases would
yield only further macrobleed overgrowth. The ranges tested were:
a, 0.0001 to 0.05 in steps of 0.0001; t, 0.1 to 50 in steps of 0.1; and
b, at 500 and 5000.
Figure 1. Simulated hemorrhage growth. Shearing forces from a
primary rupture (panel A, red) generate possible secondary ruptures at
neighboring segments (B, black arrows). Secondary vessel ruptures
(dark blue) then contribute to possible further ruptures in subsequent
cycles (C, D). The probability of adjacent rupture declines exponentially
with each cycle, simulating coagulation (lightening arrows).
doi:10.1371/journal.pone.0048458.g001
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patients taking anticoagulant medications), we also performed
more in-depth analyses on three values of the ‘‘coagulation
factor’’ t (9, 11, and 13) at fixed a (0.01) and b (500) values
(Table 1). The three values of t were selected to represent a
physiologically realistic range of the coagulation process in
which both microbleeds and macrobleeds could occur (illustrat-
ed in Fig. 3B). For these investigations, the full growth histories
of 10,000 simulated lesions were stored and analyzed. In
addition to determining lesion volumes and macrobleed:micro-
bleed ratios from the resulting histograms as above, we used the
growth histories to generate values for the rate and duration of
expansion. Rate of expansion was evaluated by fitting a sigmoid
growth curve to hemorrhage size as a function of time (size=A/
(1+e
2B(t2C)) where the maximal growth rate is given by AB/4
and the parameters A, B, and C selected by minimizing the chi-
square fit with the observed data using the Minuit minimization
package implemented in ROOT). Duration of expansion was
the number of cycles until growth ceased as defined above. We
also performed additional simulations in which an initial
‘‘anticoagulated’’ value of t=13 is abruptly replaced during
the course of hemorrhage expansion with the ‘‘normal
coagulation’’ value of t=9.
Statistical comparisons of continuous parameters (growth rate,
duration, and maximum hemorrhage volume) were evaluated
using Mann-Whitney tests because of non-normal distributions.
Comparisons of the fraction of microbleeds vs. macrobleeds at
different parameters were performed using a chi-square test.
The independent contributions of growth rate and duration to
final volume were analyzed by partial correlation in a model
that also included a categorical variable for the three examined
values of t.
Results
Depending on model parameters, a subset of simulated primary
vessel ruptures grew into larger hemorrhages. Representative
expanding macrobleeds are shown at discrete time points (Fig. 2)
and as a movie (Movie S1). Expansion of primary vessel ruptures
into larger hemorrhages tended to occur asymmetrically in
apparently arbitrary directions rather than concentrically around
the site of origin. Smaller lesions (single vessel ruptures or small
clusters) generally ceased growing solely by failure to trigger
further ruptures, thus ‘‘self-terminating’’ without the additional
volume-dependent contribution to reduced rupture probability
(i.e., even with ß set to high values). For larger lesions, termination
occurred by the volume-dependent pressure effect, such that at
large values of ß these lesions continued growing to the simulated
lattice limits.
Under conditions of expansion, hemorrhage volume histograms
yielded distinct peaks of smaller (microbleed) and larger (macro-
bleed) volume lesions. Whether microbleeds or macrobleeds
predominated varied according to parameter choice for expansion
(a) and decay (t) of secondary rupture. The dark blue central band
in Figure 3A represents combinations of a and t that generate a
macrobleed:microbleed ratio in a similar range to the clinically
observed bimodal distribution in ICH patients [9]. Variations in ß
typically did not affect the macrobleed:microbleed ratio, but rather
only the median volume of the lesions comprising the macrobleed
peak (data not shown).
To further understand the effects of varying the decay time
constant (corresponding to the physiologic property of coagulation
speed), we performed more in-depth analyses at three values of t
(Table 1). These values of t were selected to simulate the effects of
prolonged coagulation within a narrow, physiologically realistic
range of macrobleed:microbleed ratios. As shown in Table 1 and
Fig. 3B, increasing values of t yielded 1) higher macrobleed:micro-
bleed ratios (i.e. a higher likelihood that a given vessel rupture
would expand into the macrobleed range), and 2) larger median
volumes for the macrobleeds. To explore the mechanism
underlying the larger macrobleed volumes achieved at higher
values of t, we further analyzed the duration and rate of
hemorrhage expansion. We found that both the growth duration
(number of cycles until ceasing growth) and the maximal growth
rate (the rate parameter in the fitted sigmoid function) increased
with higher t, along with an increase in hemorrhage size (Table 1).
Controlling for the different values of t, maximal growth rate and
duration each contributed independently to final hemorrhage
volume (partial correlation coefficients 0.88 and 0.82 respectively,
p,0.001 for each).
To simulate the situation where anticoagulation is therapeuti-
cally reversed after hemorrhage is detected, we performed
additional analyses of the effect of abruptly switching from the
simulated anticoagulation condition (t=13) to simulated normal
coagulation (t=9) at various time points during the course of
hemorrhage expansion. Even under these unrealistically rapid
conditions of reversal (a process that can require 5 hours or more
in clinical practice [11]), only very early switches were effective in
substantially limiting final hematoma size (Fig. 4). Reversals
performed at time points close to the median duration of
macrobleed growth under normal conditions (198 cycles;
Table 1) prevent very little of the anticoagulation-related
enlargement in median hemorrhage size (Fig. 4).
Discussion
We report that a simulation based on rules directly derived from
neuropathological observations in hemorrhagic brain tissue [10]
Figure 2. Representative expanding macrobleed. The originating
vessel segment is shown in red, more recent ruptures in lightening
shades of blue. No further growth occurred beyond cycle 340. Run
parameters: a=0.01, t=11, b=500.
doi:10.1371/journal.pone.0048458.g002
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observed ICH. Among these are 1) a bimodal distribution of
microbleeds and macrobleeds (as found in a study of 46 patients
with lobar ICH [9]), 2) an asymmetric rather than concentric
pattern of hemorrhage expansion [12], 3) increased incidence of
macrobleeds under conditions simulating prolonged coagulation
(as observed in patients treated with anticoagulant medication
[13,14]), and 4) larger macrobleed volumes under the anticoag-
ulated condition (also observed clinically [5–7]). The similarities
between simulated and observed results are consistent with the
possibility that the current model captures at least some of the key
mechanistic features of clinical ICH expansion.
The report by Fisher [10] motivating the current model noted at
least 24 sites of recent arterial rupture within a single pontine
hemorrhage, mostly small and at the hematoma periphery. Based
on their position, absence of evident chronic arterial disease, and
large number, Fisher surmised that ‘‘all or most of the [vessel
ruptures] were the secondary result of a mechanical disruption
caused by blood escaping from a primary site of hemorrhage,’’
creating an ‘‘avalanche’’ of bleeding vessels. We previously
suggested secondary shearing could generate a bimodal distribu-
tion of ICH volumes [9]; the current simulation supports this idea.
To simulate the effects of therapeutic anticoagulation and
reversal, we further investigated the effects on hemorrhage growth
of varying the decay time constant. Small increases in t (all within
Table 1. Analysis of macrobleeds under various simulated anticoagulant conditions.
Decay
constant
Proportion of
macrobleeds Macrobleed volume
Total duration of macrobleed
growth
Maximal rate of macrobleed
growth
t (% total hemorrhage events) (median vessels, interquartile range) (median cycles, interquartile range) (median cycles
21, interquartile range)
9 26.9 111 (70–153) 198 (153–247) 0.95 (0.65–1.32)
11 53.2 * 276 (238–310) * 293 (250–347) * 2.04 (1.53–2.56) *
13 70.0 * 412 (382–440) * 310 (271–357) * 3.46 (2.92–4.03) *
All data were derived from 10,000 hemorrhage simulations (see Methods). P-values (in comparison to next lower value of t) were determined by chi-square (proportion
of macrobleeds) or Mann-Whitney test (volume, duration, rate).
*p,0.001.
doi:10.1371/journal.pone.0048458.t001
Figure 3. Effect of model parameters on distribution of hemorrhage volumes. Panel A depicts combinations of expansion coefficient a and
coagulation time constant t (b=500). Z-scale is # macrobleed/# microbleeds (log 10 ratio). Panel B shows sample histograms for bimodal conditions
with three different levels of decay constants (top: t=13; middle: t=11, bottom: t=9, all with a=0.01). Red marks in panel B indicate median size of
macrobleeds at those parameters (log value 4.71 for t=9, 5.62 for t=11, and 6.02 for t=13, corresponding to the values for macrobleed volume
shown in Table 1).
doi:10.1371/journal.pone.0048458.g003
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macrobleeds, Fig. 3) resulted in both faster rates and longer
durations of hemorrhage growth (Table 1), each of which
contributed to larger final macrobleed volumes. Growth rate
and duration have not been extensively studied in clinical ICH,
but there is evidence that prolonged duration may indeed be a
feature of anticoagulant-related hemorrhage [4]. Finally, our
model suggests that the effects of anticoagulation may determine
final hemorrhage size relatively early in the course of hematoma
growth (Fig. 4), consistent with the difficulties encountered by
several groups in demonstrating beneficial effects of anticoagula-
tion reversal [15–19].
Our computer-based model is intended as a tool for generating
and testing hypotheses on the factors that affect hemorrhage
growth. While we attempted to model some biological properties
of in vivo hemorrhages, we excluded several aspects of bleeding for
simplicity. Lesion volume, for example, was calculated as number
of ruptured vessels, neglecting the likely vessel-to-vessel variations
in volume of extruded blood. The model also does not account for
the location, heterogeneity, and anisotropy of the surrounding
brain tissue, which likely contributes to the direction of hemor-
rhage expansion in patients. It is interesting in this context that the
simulation nonetheless generated a considerable degree of
asymmetric growth, suggesting that the secondary shearing and
clotting processes may also contribute to this feature. We further
note the lack of a straightforward or quantitative connection
between model parameters (measured in arbitrary units of
simulation cycles and virtual vessel segments) and physical
parameters of human hemorrhage. Addressing these limitations
will likely require further studies correlating simulated results to
observed clinical data and greater model complexity.
A potential application for future iterations of this model will be
to dissect the individual effects of factors related to secondary
vessel shearing (a in our model) and time-dependent decay (t)o n
particular aspects of hemorrhage growth. Although they are
parameters in a virtual model, both a and t may correspond to
identifiable physical features in ICH. Likelihood of secondary
vessel rupture, for example, would be expected to relate to small
vessel structure. Alterations of vessel structure have indeed been
postulated to account for some findings in hemorrhage expansion,
such as the effect of the apolipoprotein E e2 allele on growth of
cerebral amyloid angiopathy-related ICH [20,21]. Time-depen-
dent decay of rupture, conversely, would be expected to depend on
hemostatic factors such as the coagulation cascade, another
observed determinant of hemorrhage volume [22,23]. Future
comparisons of observed to simulated data might further help
unravel the mechanisms of other interventions affecting hemor-
rhage expansion, such as acute blood pressure lowering [24,25].
As final hematoma size is a powerful determinant of patient
outcome [2] and continued expansion after clinical presentation
occurs in approximately one-quarter to one-third of macrobleeds
imaged early after presentation [24–26], the identified steps in this
process will be important future targets for exploration and
treatment.
Supporting Information
Movie S1 Examples of simulated hemorrhages. All simulated
lesions were allowed to grow until termination. Run parameters:
a=0.01, t=10.0, b=500 (within the region of bimodal
distribution in Figure 3A). See legend to Figure 2 for color scheme.
(MOV)
Figure 4. Effect of simulated reversal of anticoagulation. The simulated anticoagulation condition (t=13) was abruptly switched to simulated
normal coagulation (t=9) at the time points indicated on the x-axis during the course of hemorrhage expansion. Simulations were otherwise
performed as described in Table 1.
doi:10.1371/journal.pone.0048458.g004
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